Dolon is a leading, strategic consultancy specialising in market access for rare disease medicines. We partner and provide incisive strategic guidance to multinational pharmaceutical companies on a variety of market access and policy issues globally. Our goal is to ensure that effective rare disease treatments are made accessible to the patients who need them, in a way that is sustainable for both the pharmaceutical industry and society. Our market access specialists deliver solutions at a therapy, disease, portfolio and industry level to realise success throughout the product life cycle. We provide services in the following areas: • Value, Price and Access • Market Access Policy • Analytics Headquartered in London, and with offices globally, we are a team of enthusiastic and intellectually curious individuals who share a passion for collaboration and solving complex problems.
